Literature DB >> 10335772

Elevated circulating levels and cardiac secretion of soluble Fas ligand in patients with congestive heart failure.

S Yamaguchi1, M Yamaoka, M Okuyama, J Nitoube, A Fukui, M Shirakabe, K Shirakawa, N Nakamura, H Tomoike.   

Abstract

The circulating levels of soluble Fas ligand was increased in patients with advanced congestive heart failure. This study also indicates that the failing heart may contribute to the increased concentration of soluble Fas ligand in patients with congestive heart failure.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10335772     DOI： 10.1016/s0002-9149(99)00133-2

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


  11 in total

1.  Alpha-lipoic acid improves subclinical left ventricular dysfunction in asymptomatic patients with type 1 diabetes.

Authors:  Sahar K Hegazy; Osama A Tolba; Tarek M Mostafa; Manal A Eid; Dalia R El-Afify
Journal:  Rev Diabet Stud       Date:  2013-05-10

2.  Lymphocyte Apoptosis and FAS Expression in Patients with 22q11.2 Deletion Syndrome.

Authors:  Dina M Aresvik; Torstein Øverland; Kari Lima; Rolf D Pettersen; Tore G Abrahamsen
Journal:  J Clin Immunol       Date:  2018-12-19       Impact factor: 8.317

Review 3.  Biomarkers in heart failure: the past, current and future.

Authors:  Michael Sarhene; Yili Wang; Jing Wei; Yuting Huang; Min Li; Lan Li; Enoch Acheampong; Zhou Zhengcan; Qin Xiaoyan; Xu Yunsheng; Mao Jingyuan; Gao Xiumei; Fan Guanwei
Journal:  Heart Fail Rev       Date:  2019-11       Impact factor: 4.214

4.  Fas and fas ligand are up-regulated in pulmonary edema fluid and lung tissue of patients with acute lung injury and the acute respiratory distress syndrome.

Authors:  Kurt H Albertine; Matthew F Soulier; Zhengming Wang; Akitoshi Ishizaka; Satoru Hashimoto; Guy A Zimmerman; Michael A Matthay; Lorraine B Ware
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

5.  Myocardial Fas and cytokine expression in end-stage heart failure: impact of LVAD support.

Authors:  Maninder S Bedi; Rene J Alvarez; Toru Kubota; Richard Sheppard; Robert L Kormos; Michael P Siegenthaler; Arthur M Feldman; Charles F McTiernan; Dennis M McNamara
Journal:  Clin Transl Sci       Date:  2008-12       Impact factor: 4.689

Review 6.  TNF revisited: osteoprotegerin and TNF-related molecules in heart failure.

Authors:  Thor Ueland; Arne Yndestad; Christen P Dahl; Lars Gullestad; Pål Aukrust
Journal:  Curr Heart Fail Rep       Date:  2012-06

Review 7.  Mechanisms of apoptosis in the heart.

Authors:  Asa B Gustafsson; Roberta A Gottlieb
Journal:  J Clin Immunol       Date:  2003-11       Impact factor: 8.317

8.  Impaired thymic export and apoptosis contribute to regulatory T-cell defects in patients with chronic heart failure.

Authors:  Ting-Ting Tang; Zheng-Feng Zhu; Jun Wang; Wen-Cai Zhang; Xin Tu; Hong Xiao; Xin-Ling Du; Jia-Hong Xia; Nian-Guo Dong; Wei Su; Ni Xia; Xin-Xin Yan; Xing-Xing Yan; Shao-Fang Nie; Juan Liu; Su-Feng Zhou; Rui Yao; Jiang-Jiao Xie; Harish Jevallee; Xiang Wang; Meng-Yang Liao; Guo-Ping Shi; Michael Fu; Yu-Hua Liao; Xiang Cheng
Journal:  PLoS One       Date:  2011-09-15       Impact factor: 3.240

Review 9.  Morphological aspects of apoptosis in heart diseases.

Authors:  Genzou Takemura; Hisayoshi Fujiwara
Journal:  J Cell Mol Med       Date:  2006 Jan-Mar       Impact factor: 5.310

10.  Short term effects of milrinone on biomarkers of necrosis, apoptosis, and inflammation in patients with severe heart failure.

Authors:  David E Lanfear; Reema Hasan; Ramesh C Gupta; Celeste Williams; Barbara Czerska; Cristina Tita; Rasha Bazari; Hani N Sabbah
Journal:  J Transl Med       Date:  2009-07-29       Impact factor: 5.531
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.